Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven S Chang

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Journal of the National Cancer Institute|February 2, 2026
Salvage of locoregionally recurrent head and neck cancer: an NRG oncology working group reviewMatthew C Ward, Jung Julie Kang, Nabil F Saba, et al.
Plos One|March 24, 2009
Coordinated activation of candidate proto-oncogenes and cancer testes antigens via promoter demethylation in head and neck cancer and lung cancerIan M Smith, Chad A Glazer, Suhail K Mithani, et al.
Frontiers in Psychology|December 27, 2021
Association of Inventory to Measure and Assess imaGe Disturbance - Head and Neck Scores With Clinically Meaningful Body Image-Related Distress Among Head and Neck Cancer SurvivorsDavid Macias, Brittany N Hand, Patrik Pipkorn, et al.
Head & Neck|October 24, 2020
Systematic review of postoperative therapy for resected squamous cell carcinoma of the head and neck: Executive summary of the American Radium Society appropriate use criteriaDanielle N Margalit, Assuntina G Sacco, Jay S Cooper, et al.
The Lancet. Oncology|November 17, 2024
Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trialLoren K Mell, Pedro A Torres-Saavedra, Stuart J Wong, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Journal of the National Cancer Institute|February 2, 2026
Salvage of locoregionally recurrent head and neck cancer: an NRG oncology working group reviewMatthew C Ward, Jung Julie Kang, Nabil F Saba, et al.
Plos One|March 24, 2009
Coordinated activation of candidate proto-oncogenes and cancer testes antigens via promoter demethylation in head and neck cancer and lung cancerIan M Smith, Chad A Glazer, Suhail K Mithani, et al.
Frontiers in Psychology|December 27, 2021
Association of Inventory to Measure and Assess imaGe Disturbance - Head and Neck Scores With Clinically Meaningful Body Image-Related Distress Among Head and Neck Cancer SurvivorsDavid Macias, Brittany N Hand, Patrik Pipkorn, et al.
Head & Neck|October 24, 2020
Systematic review of postoperative therapy for resected squamous cell carcinoma of the head and neck: Executive summary of the American Radium Society appropriate use criteriaDanielle N Margalit, Assuntina G Sacco, Jay S Cooper, et al.
The Lancet. Oncology|November 17, 2024
Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trialLoren K Mell, Pedro A Torres-Saavedra, Stuart J Wong, et al.
Pageof 5